Advertisement
Advertisement
U.S. markets open in 9 hours 22 minutes
Advertisement
Advertisement
Advertisement
Advertisement

InspireMD, Inc. (NSPR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0300-0.0400 (-1.93%)
At close: 04:00PM EDT
Advertisement
Sign in to post a message.
  • J
    Jas
    26K shares and down 6%. It will take about 200K shares and it will be 25 cents. Removing RS and more. So Criminals can dilute more and continue to pay themselves. SEC can't stop this scam? They are in it too.
  • J
    Jas
    100K more shares sold and this will be 0. What a scam, the market, SEC, on and on!
  • B
    Billy
    So before taking any advice from someone in a chat room that doesn’t give any kind of real feedback do some research. First of all I am not a licensed and insured financial advisor, which actually doesn’t mean much if someone wants to sue you they will no matter what. But the product getting ready for FDA trial is a micro stent to help with preventing strokes. Since it’s a micro stent it’s less invasive and a quicker recovery time from surgery. Less time in the hospital less insurance has to pay out. Next a reverse split is them retracting a dilution. You do not lose value on a retraction you just consolidate shares and the price goes up. Why a reverse, because more then likely a mutual fund is about to invest in the stock so they must meet the mutual funds guidelines which is usually between 5 and 10 dollars for an investment. If a mutual fund is buying they will dollar average in to the stock and probably go to a 5% ownership depending on the mutual fund. Please do your own research before listening to people give you advice. Remember competitors hire people to talk bad about certain companies. Most overseas medical companies have ten and twenty year medical launches in the United States due to longer wait times for approval. Also they are just starting the approval process which can take about 4 years. I’ll be investing and Holding a position over the next year at the very least depending on the outcome of the phase trials. But this is very promising. So bears beware, because I can back my mouth up with cash money.. the California Wine Country is not scared to invest in medical innovation.
    Bullish
  • E
    Eric
    07:13 AM EST, 02/10/2021 (MT Newswires) -- Dr Gary S Roubin, Director, purchased 241,930 shares in InspireMD (NSPR) for $149,997 on Feb 08, 2021. After the Form 4 filing with the SEC, Dr Roubin owns 703,103 shares of company stock, which have a market value of $801,537 as of the prior-day closing price.
    This is the first insider transaction for the company in the last 90 days. In the preceding 90-day window of time, there were 7 transactions from 7 insiders which resulted in the net acquisition of 2,789,393 shares.
    SEC Story Link http://www.sec.gov/Archives/edgar/data/1433607/000149315221003204/xslF345X03/ownership.xml
  • S
    Stock
    Here is what is in store today, and the reason you need to buy in when this thing opens tomorrow (as well hold);

    Wednesday, January 27, 2021, “Innovative Concepts in Carotid Revascularization”

    • “12-month results from a prospective real world multicenter clinical practice of CAD using the CGuard Embolic Prevention system: the IRONGUARD 2 study.” Author: Pasqualino Sirignano, M.D., Vascular and Endovascular Surgery Division, Department of Surgery “Paride Stefanini,” Policlinico Umberto I “Sapienza,” University of Rome.

    • “Carotid artery revascularization: a systematic review and meta-analysis comparing clinical outcomes of second vs. first generation stents and CEA.” Author: Dr. Adam Mazurek, Department of Cardiac & Vascular Diseases, John Paul II Hospital, Jagiellonian University, Medical College, Krakow, Poland; on behalf of CARMEN Collaborators (CArotid Revascularization systematic review and MEta-aNalysis).
  • A
    AlSamraiee
    Today Latest News from InspireMD>> The Company Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

    InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East and Asia, today announced the closing of an upsized underwritten public offering of units for gross proceeds of approximately $20.7 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses payable by InspireMD.

    The offering is comprised of 29,032,258 Units, priced at a public offering price of $0.62 per Unit, with each Unit consisting of one share of Common Stock and one Series G Warrant to purchase one-half of one share of Common Stock, at an exercise price of $0.682 per share and expiring on the fifth anniversary of the date of issuance. The underwriter also exercised an over-allotment option to purchase an additional 4,354,838 Units consisting of 4,354,838 shares of Common Stock and/or Series G Warrants to purchase 2,177,419 shares of Common Stock in the offering.

    A.G.P./Alliance Global Partners acted as the sole book-running manager in connection with the offering
  • e
    ephraim
    Just to put this into perspective:

    this company is way over sold.

    went down tons throughout corona virus for no reason.

    FDA approval supposedly in 2021.

    already selling the product in 39 countries. Inc. EU and Israel.

    revenues expected to double next year.

    PE is insane low.

    financials looking better and better.

    yesterday 46.86M shares were traded. that's 1.5 times the entire Float. volume is massive.

    this should be a short term stock. once people see how undervalued it is and the excellent potential. even if it does not blow up today. long term this is great.

    tiny small cap so huge potential gains/losses. Diversify.
  • T
    Tsinoy Texas Boy
    this stock is easy to reach over us$150 dollars as soon as the USA FDA approved CGUARD to US MARKET
    Bullish
  • J
    Joel
    NSPR has a bright future due to huge potential market in China. NSPR should jump to 4$ in short time. as the investing market is recognizing the issue.
    Bullish
  • B
    BART
    Uplisting to NASDAQ.

    Our board of directors is recommending the Reverse Stock Split for several important reasons. Firstly, the proposed Reverse Stock Split is needed in order to allow the Company to pursue listing our shares of common stock on The Nasdaq Capital Market. We believe that an uplisting of our common stock to The Nasdaq Capital Market will make our common stock more attractive to a broader range of investors than its current listing on the NYSE American. We believe that the Reverse Stock Split is our best option to meet one of the sets of criteria to obtain an initial listing on The Nasdaq Capital Market. The Nasdaq Capital Market requires, among other criteria, an initial bid price of least $4.00 per share or a closing price of at least $3.00 per share (or, if certain other conditions are met, which may not apply to us, a closing price of at least $2.00 per share), depending on the other quantitative listing standards that are met in connection with the initial listing. Following initial listing, The Nasdaq Capital Market requires that a listed company maintain a bid price of at least $1.00 per share. On March 8, 2021, the last reported sale price of our common stock on the NYSE American was $0.79 per share. A decrease in the number of outstanding shares of our common stock resulting from the Reverse Stock Split should, absent other factors, increase the per share market price of our common stock, although we cannot provide any assurance that our minimum bid price would remain over the minimum bid price requirement of The Nasdaq Capital Market following the Reverse Stock Split.
    Bullish
  • m
    m
    Amazing 6th reverse stock split in 10 years. How do these guys sleep at night? Time for the SEC to investigate these foreign firms whose sole purpose is to enrich management and directors.
  • B
    Bill
    I do not believe we have a reverse split, IF it goes that way, that works too. In the case of $NSPR, they may already be over$4 and can list on Nasdaq. In any event, a R/S does nothing value wise to the stock, it will however require some funds to buy this stock to balance their holdings. So, from my standpoint, this is a buy right here right now. $NSPR closed on Friday at 1.19 and went to 1.28 in AH, before closing at 1.22. A big buyer bought 2.8 MILLION shares around 2pm between the prices of 1.06-1.24, I do not believe it looks back. Do your own DD ALWAYS, do not listen to a stock chat board for your financial advice. I am in this at this level 1.21- and will be a buyer Monday.
    Bullish
  • S
    Stock
    Huge day today, this stock is on everyone’s radar now over 30k followers on Stocktwits, tons of activity last week in the medical community, intracoastal Capital buying a major stake...

    $NSPR going to be $0.80+ by end of week for sure
    Bullish
  • a
    aftab
    Good News. Fourth QTR earnings report on Tuesday. Patent already granted. If earnings is positive, this stock could touch $3 plus. It’s time to accumulate!!!
  • T
    Tom M
    Just spent my last 178 bucks to buy 889 more shares. My total is 3,111. Small fry, I know, but we've gotta start somewhere.
  • J
    J75
    Hey every one, to make no share available for the shorts to to short, set your shares for sell with limit price at $100 or more so that our shares would not be in the loan list from your brokerage.
    Please like it so it can be at the top and everyone can see it. We need to united the retail investors community againts the hedge funds and shorters.
  • J
    Jazzman
    Best thing for NSPR is keep moving forward to generate sales... It's simple- More sales leads to higher stock price. business 101-
    Bullish
  • S
    Sébastien
    Reverse splits are never good...it will take time to recover the loss!
  • B
    Babalu22
    Potential x10 runner here! BNGO started at the same way!! In at 0.43 and HOLD 📈📈 target is $5+++ their products will safe lives all over the world 🌈🌈 $5+++ in 3 months
    Bullish
  • C
    Chris
    Back in 7/8/2016 I bought 2,00 shares at $0.25 ($500 total). I was new to stocks at the time and thought buying into a medical company like this would not be much of a risk. On 9/29/2016 I sold my remaining shares for $156 or a 72% loss. If I had NOT sold my shares I would have gone through yet another RS and been left with almost nothing. I was lucky looking back on this because I had only invested $500 to start with. If I had been greedy it could have been much worse.

    To me, when a company talks about doing a reverse split, that's the kiss of death. if you are thinking about staying with any stock that is planing or has been though a RS do some extra research to know what you are getting into. I consider it a very bad sign, at least for shareholders.

    And if you see a stock like this that had a very high share price in the past and think "Surely it will recover at least some of that prior loss?", check to see if it's due to a past Reverse Split. If so I would consider it a TRAP and it may happen again.

    And while I am at it, here's some advice for you beginners: Don't be greedy, and don't be afraid. Do some research and learn as much as you can first. Don't trust anyone that tells you a stock is going up or a stock is going down. Often they just WANT you to think that because they are long or short on a stock. Pay attention most of all to the FACTS, and very little to OPINION (unless you see a track record of good opinion from someone. But even then make up your own mind based on what you know about a stock).
Advertisement
Advertisement